https://www.horizonscangeneesmiddelen.nl/geneesmiddelen/patritumab-deruxtecan?versie=versie-3
Patritumab deruxtecan | Oncology | Medicines | Horizonscan geneesmiddelen
Patritumab deruxtecan monotherapy for second line or later treatment of locally advanced or metastatic EGFR-mutated non-small cell lung cancer in adults and...
patritumab deruxtecanoncologymedicinesgeneesmiddelen